A randomized, multicenter, double-blind, placebo-controlled clinical trial has provided strong evidence supporting the effectiveness of Natural Eggshell Membrane (NEM®) as a treatment for knee osteoarthritis. In the study, 67 adults diagnosed with knee osteoarthritis were given either 500 mg of NEM® once daily or a placebo over an eight-week period. The trial was designed to meet rigorous clinical research standards and aimed to evaluate both the speed and magnitude of symptom relief associated with this naturally derived supplement.

Pain and joint stiffness were assessed using the WOMAC Osteoarthritis Index, a widely accepted and validated measurement tool recommended by organizations such as the Osteoarthritis Research Society International (OARSI) and frequently used in studies referenced by the National Institutes of Health (NIH). Evaluations were conducted at 10, 30, and 60 days. Compared with placebo, participants receiving NEM® experienced statistically significant reductions in both pain and stiffness at every measured time point.

Notably, the effects of NEM® were observed rapidly. As early as day 10, mean pain scores decreased by 15.9% (P = 0.036), demonstrating a faster onset of relief than many conventional osteoarthritis treatments. These pain reductions were sustained throughout the study, remaining at a 15.4% decrease by day 60 (P = 0.038). Improvements in joint stiffness were even more pronounced, showing a steady and progressive decline over time and reaching a 26.6% reduction by day 60 (P = 0.005). According to the Arthritis Foundation, stiffness reduction is a critical outcome for improving daily mobility and quality of life in osteoarthritis patients.

Beyond average score improvements, responder analysis revealed clinically meaningful benefits for a substantial proportion of participants. By the end of the study, 32% of patients taking NEM® achieved at least a 50% reduction in pain, compared with only 12% in the placebo group. Even more striking, over half of the NEM® group experienced a 50% or greater reduction in stiffness. These results suggest that NEM® not only provides modest symptom relief but can also deliver significant improvements for many individuals.

The study also calculated the number needed to treat (NNT), a metric commonly used in evidence-based medicine to assess treatment effectiveness. The NNT for achieving a 50% reduction in stiffness at 60 days was 2.4, indicating strong therapeutic efficacy. According to clinical research standards cited by journals such as The New England Journal of Medicine, an NNT below 5 is generally considered highly favorable, particularly for chronic pain-related conditions.

Equally important, NEM® demonstrated an excellent safety profile. No serious adverse events were reported during the study, and the supplement was well tolerated by participants. This is a key consideration, as commonly used osteoarthritis treatments—including nonsteroidal anti-inflammatory drugs (NSAIDs)—are associated with gastrointestinal, renal, and cardiovascular risks, as noted by the U.S. Food and Drug Administration (FDA) and the American College of Rheumatology.

In conclusion, this clinical trial suggests that Natural Eggshell Membrane may serve as a fast-acting, effective, and low-risk alternative or complementary option for managing knee osteoarthritis symptoms. While larger and longer-term studies are still needed, the current findings position NEM® as a promising natural intervention that may help reduce pain and stiffness without the safety concerns commonly associated with long-term pharmacological therapies.